Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis.
about
Risk prediction tools for cancer in primary careRotterdam Prostate Cancer Risk Calculator: Development and Usability Testing of the Mobile Phone App.Development and external validation of a prostate health index-based nomogram for predicting prostate cancer.The Huashan risk calculators performed better in prediction of prostate cancer in Chinese population: a training study followed by a validation study.Biomarkers in localized prostate cancer.What's new in screening in 2015?Improving the evaluation and diagnosis of clinically significant prostate cancer in 2017.Clarifying the PSA grey zone: The management of patients with a borderline PSA.Racial Variation in the Utility of Urinary Biomarkers PCA3 and T2ERG in a Large Multicenter Study.Sexuality in men after prostate cancer surgery: a qualitative interview study.Prognostic implications of tissue and serum levels of microRNA-128 in human prostate cancer.Clinical Consultation Guide: How to Optimize the Use of Prostate-specific Antigen in the Current Era.Risk-prediction tools in prostate cancer: the challenge of tailoring.Current challenges in prostate cancer: an interview with Prostate Cancer UK.Letter to the editor concerning 'Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis'.Responses to provision of personalised cancer risk information: a qualitative interview study with members of the public.Recommandations de l’Association des urologues du Canada sur le dépistage et le diagnostic précoce du cancer de la prostate.Prospective evaluation on the effect of interobserver variability of digital rectal examination on the performance of the Rotterdam Prostate Cancer Risk Calculator.Prostatectomy-based validation of combined urine and plasma test for predicting high grade prostate cancer.Evidenced-based clinical practice guideline for prostate cancer (summary: Japanese Urological Association, 2016 edition).eHealth and mHealth in prostate cancer detection and active surveillance.Head-to-head comparison of prostate cancer risk calculators predicting biopsy outcome.On cribriform prostate cancer.Multivariable risk-based patient selection for prostate biopsy in a primary health care setting: referral rate and biopsy results from a urology outpatient clinic.Prostate Cancer in Primary CareReply to the letter to the editor ‘Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis’ by Louie et alDevelopment and Internal Validation of Novel Nomograms Based on Benign Prostatic Obstruction-Related Parameters to Predict the Risk of Prostate Cancer at First Prostate Biopsy
P2860
Q26774974-A29E5903-7BA9-43B3-B9C1-404514F71709Q33454007-620C106B-D8A6-48C4-BF64-5C96991D3350Q36168333-D7D33A84-B93D-4138-AF5F-3A1F2A444071Q37414994-5F3A2052-B205-406D-AF69-4C853E1E1521Q38697114-42B2D22D-427A-400E-949A-30C14B77AD96Q38871819-CBA3D965-4AD9-4F80-B81B-35ED3EA95A3CQ38950445-CD220582-DB27-4D8F-BB85-7DA564D1DD3BQ38965360-B857CB2A-BBD7-4E6F-A476-497B824D9742Q39003646-C96ECFEC-E3D5-4FDC-865C-B3993DC67770Q39853527-9A608039-26F9-4C1B-BD67-90183CE56064Q40574583-7980911E-3A44-46B4-A916-8F3AF10E6C75Q41201216-3D63F16F-7C18-49CE-9A5C-5B55B23AD406Q42139173-55F50D12-6776-4D3B-A831-70EE8A7B4431Q42384087-01DC887D-912D-49F2-8F31-B295E198F9D9Q42399368-EA01A3E4-AFBD-4CC9-A11C-D9CBDA99322CQ47096048-DDE13D95-33BE-4F9E-89A7-A9F9C69D0828Q47123251-E82107D7-509D-4094-8237-AF83A5E02673Q47689171-6D6F5D25-C70F-4ABC-963E-6F06267E4D9EQ48282722-3855C581-7181-4C37-884B-20F9E96870BDQ53734447-7755DBBE-53DC-49BF-AC39-C24556BBB838Q54961599-46ACA9E2-EA6A-4DAC-9EED-4A5AF5DFD579Q54996710-BD033AE5-226A-4371-9509-43EE7E22DBA8Q55020762-8D09E2B8-F9D2-47A8-9D17-44E8C7307266Q55139905-E11A6286-113F-4381-9228-9D9B367FF0D6Q57106542-84EC2315-4828-4E04-8FA6-9893D9628388Q57414760-097EA2B6-960E-4731-9739-E304E8B3359DQ58554083-6DD3F34B-5903-41FA-85C2-B34041DF9ABB
P2860
Do prostate cancer risk models improve the predictive accuracy of PSA screening? A meta-analysis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Do prostate cancer risk models ...... SA screening? A meta-analysis.
@en
type
label
Do prostate cancer risk models ...... SA screening? A meta-analysis.
@en
prefLabel
Do prostate cancer risk models ...... SA screening? A meta-analysis.
@en
P2093
P2860
P356
P1433
P1476
Do prostate cancer risk models ...... SA screening? A meta-analysis.
@en
P2093
A Seigneurin
P Cathcart
P2860
P304
P356
10.1093/ANNONC/MDU525
P577
2014-11-17T00:00:00Z